Buspirone Dosing and Administration
Start buspirone at 15 mg daily (7.5 mg twice daily), increase by 5 mg per day every 2-3 days as needed, with a maximum dose of 60 mg daily, and maintain consistent timing with regard to food intake. 1
Initial Dosing
- Starting dose: 15 mg/day divided as 7.5 mg twice daily 1
- Alternative starting dose for specific populations: 5 mg twice daily may be used in elderly patients or those with Alzheimer's disease 2
- Food considerations: Take consistently either always with food or always without food, as bioavailability increases when taken with food 1
Titration Schedule
Standard titration: Increase by 5 mg per day at intervals of 2-3 days as clinically indicated 1. Clinical trials commonly employed divided doses of 20-30 mg/day 1.
Therapeutic response timeline:
- Anxiolytic effects may require 2-4 weeks to become fully effective 2
- Unlike benzodiazepines, buspirone lacks immediate anxiolytic action
- Peak plasma levels occur 40-90 minutes after oral administration
Maximum Dosing
- Maximum daily dose: 60 mg/day 1
- Clinical studies have used doses up to 90 mg/day for depression 3, 4, though the FDA-approved maximum remains 60 mg/day
- Most effective dose range: 20-30 mg/day for anxiety 1; 40-54 mg/day showed efficacy in depression trials 3, 4
Special Populations and Dose Adjustments
Elderly/Alzheimer's Patients
- Start at 5 mg twice daily
- Maximum 20 mg three times daily (60 mg/day total) 2
- Useful only in mild to moderate agitation
- Slower titration recommended
Pediatric/Autism Spectrum Disorder
- Limited evidence for specific dosing
- Studies have used 0.1-2.0 mg/kg with variable effects 5
- Lower doses (0.1-0.3 mg/kg) showed cognitive benefits 5
Drug Interactions Requiring Dose Reduction
When combined with potent CYP3A4 inhibitors, use significantly reduced doses:
- With erythromycin, itraconazole, or nefazodone: Start at 2.5 mg twice daily or 2.5 mg once daily 1
- With diltiazem or verapamil: Dose reduction necessary; start low and titrate based on clinical response 1
- With grapefruit juice: Avoid large amounts (causes 9-fold increase in AUC) 1
With CYP3A4 inducers (rifampin, phenytoin, carbamazepine):
- May need higher doses to maintain anxiolytic effect due to increased metabolism 1
Critical Precautions
MAOI Interactions
Allow at least 14 days between:
- Discontinuing an MAOI and starting buspirone
- Stopping buspirone and starting an MAOI 1
Reversible MAOIs (Linezolid, Methylene Blue)
- Do not start buspirone in patients receiving these agents
- If urgent treatment with linezolid/methylene blue needed in patient on buspirone:
- Stop buspirone immediately
- Monitor for serotonin syndrome for 2 weeks or 24 hours after last dose of MAOI (whichever comes first)
- May resume buspirone 24 hours after last MAOI dose 1
Administration Considerations
Consistency is Key
- Always take with food OR always without food—not interchangeably 1
- Food increases bioavailability, so switching patterns can cause variable drug levels
Monitoring
- No routine laboratory monitoring required
- Monitor for therapeutic response at 2-4 weeks
- Assess for side effects: dizziness, nervousness, headache (most common) 6
Discontinuation
- Unlike benzodiazepines, buspirone does not cause physiologic dependence 6
- No specific tapering protocol required
- However, for patients on long-term therapy, gradual discontinuation over 10-14 days may minimize any withdrawal symptoms 2
Common Pitfalls to Avoid
- Expecting immediate anxiolytic effect: Patients switching from benzodiazepines need counseling that buspirone requires 2-4 weeks for full effect
- Inconsistent food timing: Variable absorption can lead to fluctuating drug levels and inconsistent response
- Ignoring drug interactions: CYP3A4 inhibitors can increase buspirone levels 5-20 fold 1
- Premature discontinuation: Many patients discontinue before adequate trial duration
- Using in acute anxiety/panic: Buspirone is ineffective for acute anxiety or panic attacks; it's for generalized anxiety disorder only
Overdose Management
- Doses up to 375 mg have been studied with symptoms of nausea, vomiting, dizziness, drowsiness, miosis, and gastric distress 1
- No specific antidote exists
- Treatment: gastric lavage, supportive care, monitor vital signs 1
- Dialyzability unknown 1
- No deaths reported from buspirone alone; fatal cases involved multiple drugs/alcohol 1